arrow
R

René Rettl

Medical University of Vienna
H指数:16
被引数:770

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CMR-derived skeletal muscle T1 time and extracellular volume as novel diagnostic markers for cardiac amyloidosis

CMR衍生的骨骼肌T1时间和细胞外容积作为心脏淀粉样变的新的诊断标志物

2026-03-300
OAAI
Coronary Artery Disease in Cardiac Amyloidosis: Prevalence, Clinical Relevance, and Cardiac Magnetic Resonance Imaging Features

心脏淀粉样变性中的冠状动脉疾病:患病率、临床相关性及心脏磁共振成像特征

2025-12-130
OAAI
Impact of disease-modifying therapy on [99mTc]Tc-DPD SPECT/CT markers in transthyretin cardiac amyloidosis enabled by artificial intelligence

人工智能赋能的疾病修饰性疗法对转甲状腺素蛋白心脏淀粉样变性[99mTc]Tc-DPD SPECT/CT标志物的影响

2025-11-290
OAAI
Additive diagnostic value of thoracic SPECT/CT imaging in perugini grade 1 patients who underwent bone scintigraphy

在行骨闪烁显像的佩鲁吉尼1级患者中,胸部SPECT/CT成像的附加诊断价值

2025-11-120
OAAI
Left atrial appendage thrombi despite oral anticoagulation in transthyretin amyloid cardiomyopathy patients undergoing electrical cardioversion for atrial fibrillation or − flutter

尽管接受了口服抗凝治疗,转甲状腺素蛋白淀粉样变性心肌病患者在为心房颤动或心房扑动进行电复律时仍出现左心耳血栓。

2025-10-080
OAAI
Serial extracellular volume quantification using cardiac magnetic resonance imaging in transthyretin amyloidosis patients treated with tafamidis

使用心脏磁共振成像对接受tafamidis治疗的转甲状腺素蛋白淀粉样变性患者的血清外容积进行连续量化

2025-07-160
OA
Cardiopulmonary Exercise Testing Correlates with Quantitative Left Ventricular [99mTc]-DPD Uptake in Transthyretin Amyloid Cardiomyopathy

心肺运动试验与转甲状腺素蛋白淀粉样变性心肌病定量左心室[99mTc]-DPD摄取的相关性

2025-04-260
OA
Functional capacity testing in patients with pulmonary hypertension (PH) using the one-minute sit-to-stand test (1-min STST) (vol 18, e0282697, 2023)

肺动脉高压(PH)患者的一分钟坐站测试(1-min STST)功能能力测试(vol 18, e0282679, 2023)

2025-01-160
OA
His108Arg Transthyretin Amyloidosis-Shedding Light on a Distinctively Malignant Variant

His108Arg转甲状腺素蛋白淀粉样变性-在一种明显的恶性变体上脱落

2024-12-230
OAAI
Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing-A multicentre study
2024-11-141
OA
Native skeletal muscle T1-time on cardiac magnetic resonance: A predictor of outcome in patients with heart failure with preserved ejection fraction
2024-11-011
OAAI